SCHEMBL7773152

SCHEMBL7773152

NS(=O)(=O)c1ccc(-c2nn(Cc3ccccc3)c(COCc3ccccc3)c2-c2ccc(Cl)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 5/20 0.58
PTGS1 P23219 3/20 0.58
HTR7 P34969 2/20 0.43
HTR1A P08908 1/20 0.43
HTR2A P28223 1/20 0.43
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ENPP1 P22413 1/20 0.41
CHRNA7 P36544 1/20 0.40
CA12 O43570 7/20 0.40
CA1 P00915 7/20 0.40
CA2 P00918 7/20 0.40
CA9 Q16790 7/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7780642 0.92 PTGS2 (0.56) PTGS2PTGS1LMNACYP3A4CHRNA7
SCHEMBL7773228 0.91 PTGS2 (0.55) PTGS2PTGS1CHRNA7CA12CA1
SCHEMBL7779927 0.91 PTGS2 (0.48) PTGS2PTGS1LMNACYP3A4CYP2C9
SCHEMBL7779404 0.90 PTGS2 (0.49) PTGS2PTGS1HTR7HTR1AHTR2A
SCHEMBL7780730 0.89 PTGS2 (0.54) PTGS2PTGS1HTR7HTR1AHTR2A
SCHEMBL7779396 0.89 PTGS2 (0.54) PTGS2PTGS1HTR7HTR1AHTR2A
SCHEMBL7777321 0.86 PTGS2 (0.47) PTGS2PTGS1HTR7HTR1AHTR2A
SCHEMBL8630521 0.86 PTGS1 (0.45) PTGS2PTGS1HTR7HTR1AHTR2A
SCHEMBL7779401 0.84 PTGS2 (0.54) PTGS2PTGS1LMNACYP3A4CHRNA7
SCHEMBL7779966 0.83 PTGS2 (0.48) PTGS2PTGS1LMNACYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed